therapeutic compounds (Dizal Pharmaceutical)

N/A

Report date: 2025/03/20 09:41:43
NME

Base Information

Drug Nametherapeutic compounds (Dizal Pharmaceutical)
Drug Alias Nametherapeutic compounds (AstraZeneca)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic DiseasesCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMetabolic DiseasesCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A